Fuse Medical
OTC: FZMDFort Worth, US · Delaware corporation
Find your way into Fuse Medical
Sign up to see every warm intro you have to Fuse Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fuse Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fuse Medical develops orthopedic medical devices for spine, joint, and sports medicine applications. The company offers products across cervical plating, interbodies, trauma, and biologics for the orthopedic marketplace.
Founders & leadership
CC

Christopher C. ReegChief Executive OfficerChristopher C. Reeg has spent 30 years in executive leadership roles across medical device and healthcare services companies, ranging from startups to public enterprises. He serves as Executive Officer and Director at Fuse Medical, which develops orthopedic devices for spine, joint, and sports medicine applications.
DH
David HexterExecutive
WE
William E. McLaughlinChairman, Audit Committee2016–2021William E. McLaughlin is a finance executive with 25 years of experience in accounting, finance, and treasury roles at public and private companies. He holds an MBA from Indiana University's Kelley School of Business, is a CPA, and currently serves as CFO, SVP, Treasurer, and Board member at Fuse Medical.
CC
Christopher C. PrattExecutive
JB
Jonathan BrownExecutive
AD
Alan D. MeekerExecutive
LS

Lawrence S. YellinChief Financial Officer2022–2025Lawrence S. Yellin is Chief Financial Officer, Treasurer, and Director at Fuse Medical, an orthopedic medical device company. He holds a CPA certification and has held financial leadership roles at publicly traded and private companies in manufacturing, medical devices, and consumer goods, with experience in financial restructuring, global operations management, and financial reporting.
Board
RH
Robert H. DonehewBoard director
Reported raises · per SEC filings
Form D private placements$5.8M disclosed across 3 of 4 rounds · 2014–2018
▶$3.3MraisedAug 2018 · 2 investors · Other Health CareRule 506(b)
▶$3.3MraisedAug 2018 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Renato V BositaDirector
- Ricky Raj S KalraDirector
- William E McLaughlinExecutive Officer, Director
- Christopher C ReegExecutive Officer, Director
- Mark W BrooksExecutive Officer, Director
- Offering amount
- $3.3M
- Amount sold
- $3.3M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedOct 2017 · 5 investors · Other Health CareRule 506(b)
▶$1.8MraisedOct 2017 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark W BrooksDirector
- Renato V BositaDirector
- Ricky Raj S. KalraDirector
- William E McLaughlinExecutive Officer, Director
- Christopher C ReegExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$720KraisedJan 2017 · 2 investors · Other Health CareRule 506(b)
▶$720KraisedJan 2017 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert H. DonehewDirector
- Christopher C. ReegExecutive Officer, Director
- Rusty SheltonExecutive Officer
- David HexterExecutive Officer
- Mark W. BrooksExecutive Officer, Director
- William E. McLaughlinDirector
- Christopher C. PrattExecutive Officer, Director
- Offering amount
- $720K
- Amount sold
- $720K
- Minimum investment
- $320K
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedJun 2014 · 49 investors · Other Health CareRule 506(b)
▶Undisclosed amountofferedJun 2014 · 49 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Rusty SheltonExecutive Officer, Director
- Jonathan BrownExecutive Officer, Director
- Chris PrattExecutive Officer, Director
- Alan D. MeekerExecutive Officer, Director
- David HexterExecutive Officer
- First sale
- May 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
BregThis page is an affiliate partner listing for Breg, not a company profile page. It contains contact information for medical equipment distributors and partners that provide orthopedic braces, prosthetics, and related medical supplies on behalf of Breg.
Globus MedicalGlobus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.
Smith+NephewSmith+Nephew is a medical technology company that develops products for the repair, regeneration, and replacement of soft and hard tissue, including sports medicine solutions for treating sporting injuries. Its technology is used by surgeons to help patients recover and regain mobility.
Companies working in the same space as Fuse Medical.
In the news
Frequently asked questions
- What does Fuse Medical do?
- Fuse Medical develops orthopedic medical devices for spine, joint, and sports medicine applications. The company offers products across cervical plating, interbodies, trauma, and biologics for the orthopedic marketplace.
- How much funding has Fuse Medical raised?
- Fuse Medical has disclosed $5.8M raised across 3 of its 4 known rounds.
- Where is Fuse Medical headquartered?
- Fuse Medical is headquartered in Fort Worth, US.

